Literature DB >> 23859056

Clinical and radiological outcomes in 153 patients undergoing oblique corpectomy for cervical spondylotic myelopathy.

Ari G Chacko1, Mazda K Turel, Sauradeep Sarkar, Krishna Prabhu, Roy T Daniel.   

Abstract

OBJECTIVE: To document the clinical and radiological outcomes in a large series of patients undergoing the oblique cervical corpectomy (OCC) for spondylotic myelopathy.
MATERIALS AND METHODS: We retrospectively analyzed our series of 153 patients undergoing OCC for cervical spondylotic myelopathy (CSM) over the last 10 years. A mean clinical follow-up of 3 years was obtained in 125 patients (81.7%), while 117 patients (76.5%) were followed up radiologically. Neurological function was measured by the Nurick grade and the modified Japanese Orthopedic Association score (JOA). Plain radiographs and magnetic resonance images (MRI) were reviewed.
RESULTS: Ninety-two percent were men with a mean age of 51 years and a mean duration of symptoms of 18 months. Sixty-one had a single level corpectomy, 66 had a 2-level, 24 had a 3-level, and two had a 4-level OCC. There was statistically significant improvement (p < 0.05) in both the Nurick grade and the JOA score at mean follow-up of 34.6 ± 25.4 months. Permanent Horner's syndrome was seen in nine patients (5.9%), postoperative C5 radiculopathy in five patients (3.3%), dural tear with CSF leak in one patient (0.7%), and vertebral artery injury in one patient (0.7%). Of the 117 patients who were followed up radiologically, five patients (4.3%) developed an asymptomatic kyphosis of the cervical spine while 22 patients (25.6%) with preoperative lordotic spines had a straightening of the whole spine curvature.
CONCLUSIONS: The OCC is a safe procedure with good outcomes and a low morbidity for treating cervical cord compression due to CSM. This procedure avoids graft-related complications associated with the central corpectomy, but is technically demanding.

Entities:  

Mesh:

Year:  2013        PMID: 23859056     DOI: 10.3109/02688697.2013.815326

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

1.  Answer to the letter to the editor of J.M. Duart Clemente et al. concerning "multilevel oblique corpectomy for cervical spondylotic myelopathy preserves segmental motion" by AG Chacko, M Joseph, MK Turel, K Prabhu, RT Daniel, KS Jacob (2012) Eur Spine J. 2012;21(7):1360-1367.

Authors:  Ari George Chacko; Mathew Joseph; Mazda Keki Turel; Krishna Prabhu; Roy Thomas Daniel; K S Jacob
Journal:  Eur Spine J       Date:  2013-07-24       Impact factor: 3.134

Review 2.  Oblique corpectomy in the cervical spine.

Authors:  Tomasz Tykocki; Łukasz A Poniatowski; Marcin Czyz; Guy Wynne-Jones
Journal:  Spinal Cord       Date:  2017-12-05       Impact factor: 2.772

3.  Brown-Séquard syndrome without vascular injury associated with Horner's syndrome after a stab injury to the neck.

Authors:  Stephen Johnson; Margaret Jones; Jennifer Zumsteg
Journal:  J Spinal Cord Med       Date:  2015-02-09       Impact factor: 1.985

4.  Cervical cord decompression using extended anterior cervical foraminotomy technique.

Authors:  Sung-Duk Kim; Ho-Gyun Ha; Cheol-Young Lee; Hyun-Woo Kim; Chul-Ku Jung; Jong Hyun Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31

5.  Rare Complications of Cervical Spine Surgery: Horner's Syndrome.

Authors:  Vincent C Traynelis; Hani R Malone; Zachary A Smith; Wellington K Hsu; Adam S Kanter; Sheeraz A Qureshi; Samuel K Cho; Evan O Baird; Robert E Isaacs; Ra'Kerry K Rahman; Galina Polevaya; Justin S Smith; Christopher Shaffrey; P Justin Tortolani; D Alex Stroh; Paul M Arnold; Michael G Fehlings; Thomas E Mroz; K Daniel Riew
Journal:  Global Spine J       Date:  2017-04-01

6.  Anterior Surgical Techniques for Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations.

Authors:  Harsh Deora; Se-Hoon Kim; Sanjay Behari; Satish Rudrappa; Vedantam Rajshekhar; Mehmet Zileli; Jutty K B C Parthiban
Journal:  Neurospine       Date:  2019-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.